Cure MAPT FTD

Member

Cure MAPT FTD is a global patient advocacy organization focused on finding a cure for a MAPT-gene mutation; this results in frontotemporal dementia (FTD), with disease onset typically in one’s 40s and 50s. Cure MAPT FTD unites families, researchers, and advocates worldwide to push for a disease-modifying solution. This tauopathy has yet to have a single medical trial, so by demonstrating this disease is severely undercounted, Cure MAPT FTD hopes to convince researchers, pharmaceutical executives, and governmental bodies to greenlight these potentially life-saving trials and expand labeling for the tau-related medications emerging onto the marketplace. For more information, visit curemaptftd.org